Pulmonx Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LUNG | 2216.HK | ELMD | VMD | WOK | TCMD | |
|---|---|---|---|---|---|---|
| Market cap | 121.54M | 297.80M | 232.12M | 385.07M | 4.65M | 608.87M |
| P/E (TTM) | — | — | 21.5 | 28.1 | — | 26.4 |
| Forward P/E | -3.1 | — | 45.9 | 25.3 | — | 18.5 |
| Price/book | 3.6 | 0.3 | 4.3 | 2.7 | 0.0 | 2.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +56.35% | −77.82% | +15.08% | +61.50% | −100.00% | +13.87% |
| Today | +4.04% | −0.88% | +4.83% | +6.93% | −1.89% | +9.69% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All LUNG news ›Head-To-Head Survey: Pulmonx (NASDAQ:LUNG) and Medline (NASDAQ:MDLN)
Posted by Danessa Lincoln on Oct 31st, 2026 Pulmonx (NASDAQ:LUNG – Get Free Report) and Medline (NASDAQ:MDLN – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based…
Pulmonx reiterates $90M-$92M 2026 revenue outlook while guiding to $108M-$109M operating expenses
Earnings Call Insights: Pulmonx (LUNG) Q3 2026 Management tied U.S. performance to tighter execution under its "near-to-far" commercialization framework, with CEO French saying, "We are seeing evidence that our sharper focus on fewer…
Pulmonx Corporation (LUNG) Q3 2026 Earnings Call Transcript
Pulmonx Corporation (LUNG) Q3 2026 Earnings Call October 27, 2026 4:30 PM EDT Glendon French - CEO, President & DirectorDerrick Sung - CFO & COO Webb Campbell - Gilmartin Group LLCJohn Young - Canaccord Genuity Corp., Research DivisionAnna…
Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
The Manila Times Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026 REDWOOD CITY, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx”), a global leader in minimally
Analyzing Precision Optics (NASDAQ:POCI) and Pulmonx (NASDAQ:LUNG)
Posted by Michael Walen on Oct 10th, 2026 Precision Optics (NASDAQ:POCI – Get Free Report) and Pulmonx (NASDAQ:LUNG – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- seekingalpha.com2
- themarketsdaily.com2
- manilatimes.net1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.